Fig. 2From: Temperature-controlled Laminar Airflow (TLA) in symptomatic severe asthma – a post hoc analysis of severe exacerbations, quality of life and health economicsRates of severe asthma exacerbations over 12 months for TLA (red) vs placebo (blue) for patients with ACQ7 > 3, EQ5D-VAS ≤ 65 and AQLQ≤4, and for all patients in the full studyBack to article page